Skip to main content
MarketsSingle-sourceLow
2.1

SB1 Markets initiates coverage of Apotea with buy rating

SB1 Markets has initiated coverage of Swedish online pharmacy Apotea, assigning a buy rating and a 90 SEK price target. The firm cites Apotea's position as a cost leader within the sector as the primary driver for the positive outlook.

Dagens Industriabout 4 hours agoSECredibility 27%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

Locations

Stockholm

Entities

country
Source

Related signals

8 found